COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1153: Articles 11521-11530  | Next

A mixed-methods study of risk factors and experiences of healthcare workers tested for the novel coronavirus in Canada
Okpani, A. I., Barker, S., Lockhart, K., Grant, J. M., Delgado-Ron, J. A., Zungu, M., Naicker, N., Ehrlich, R., Yassi, A.
10.1101/2021.12.04.21267231 — Posted: 2021-12-05
Brain Injury in COVID-19 is Associated with Autoinflammation and Autoimmunity
Needham, E. J., Ren, A. L., Digby, R. J., Outtrim, J. G., Chatfield, D. A., Newcombe, V. F., Doffinger, R., Barcenas-Morales, G., Fonseca, C., Taussig, M. J., Burnstein, R. M., Dunai, C., Sithole, N., Ashton, N. J., Zetterberg, H., Gisslen, M., Arvid, E., Marklund, E., Griffiths, M. J., Cavanagh, J., Breen, G., Irani, S. R., Elmer, A., Kingston, N., Bradley, J. R., Taams, L. S., michael, B. D., Bullmore, E. T., Smith, K. G., Lyons, P. A., Coles, A. J., Menon, D. K., Cambridge NeuroCOVID Group, , NIHR Cambridge Covid BioResource, , NIHR Cambridge Clinical Research Facility
10.1101/2021.12.03.21266112 — Posted: 2021-12-05
Long Term Humoral Immunity Decline in Hemodialysis Patients Following SARS-CoV-2 Vaccination
Goggins, E., Sharma, B., Ma, J. Z., Gautam, J., Bowman, B.
10.1101/2021.12.01.21265957 — Posted: 2021-12-05
Introduction and community transmission of SARS-CoV-2 lineage A.2.5 in Florida with novel spike INDELS
Schmedes, S. E., Azarian, T., Cella, E., Motes, J., Tekin, O., Weiss, J., Miller, N., Blanton, J.
10.1101/2021.12.03.21266538 — Posted: 2021-12-05
Disruptions in Care: Consequences of the COVID-19 Pandemic in a Children's Hospital
Diskin, C., Orkin, J., Dharmaraj, B., Agarwal, T., Parmar, A., Mc Naughton, K., Cohen, E., Sunderji, A., Faraoni, D., Fecteau, A., Fischer, J., Mahant, S., Friedman, J.
10.1101/2021.12.02.21266778 — Posted: 2021-12-05
The impact of the COVID-19 pandemic on children with medical complexity
Diskin, C., Buchanan, F., Cohen, E., Dewan, T., Diaczun, T., Gordon, M., Lee, E., Moore Hepburn, C., Major, N., Orkin, J., Patel, H., Gill, P.
10.1101/2021.12.02.21266765 — Posted: 2021-12-05
Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic review
Vaughan, A. M., Duffell, E. F., Friedl, G. S., Lemos, D. S., Funk, T., Nardone, A., Valenciano, M., Subissi, L., Bergeri, I., Broberg, E., Penttinen, P., Pebody, R., Keramarou, M.
10.1101/2021.12.02.21266897 — Posted: 2021-12-05
Guillain-Barre Syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink
Hanson, K. E., Goddard, K., Lewis, N., Fireman, B., Myers, T. R., Bakshi, N., Weintraub, E., Donahue, J. G., Nelson, J. C., Xu, S., Glanz, J. M., Williams, J. T., Alpern, J. D., Klein, N. P.
10.1101/2021.12.03.21266419 — Posted: 2021-12-05 Discussion: Onsite
Comparing human and model-based forecasts of COVID-19 in Germany and Poland
Bosse, N. I., Abbott, S., Bracher, J., Hain, H., Quilty, B. J., Jit, M., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, , van Leeuwen, E., Cori, A., Funk, S.
10.1101/2021.12.01.21266598 — Posted: 2021-12-05
The reactogenicity and immunogenicity of a booster dose after the second dose of a protein subunit vaccine MVC-COV1901.
Hsieh, S.-M., Chang, S.-c., Cheng, H.-Y., Shih, S.-R., Lien, C. E.
10.1101/2021.12.01.21267115 — Posted: 2021-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).